Facet Life Sciences

Facet Life Sciences is a regulatory affairs and product development consultancy that provides strategic and tactical support to small and mid-sized biopharmaceutical companies. The company specializes in guiding clients through the complex FDA regulatory landscape, offering services such as IND, NDA, and BLA submissions, regulatory strategy, and project management. Facet is known for its collaborative approach, providing expert-level involvement to help organizations navigate the path from discovery to commercialization. In 2023, the company was acquired by Target Health, a full-service CRO, to enhance their combined regulatory and clinical trial offerings.